No significant associations were observed between genotype-derived combined CYP3A metaboliser phenotype (CYP3A4/CYP3A5) and development of peripheral neuropathy or severe peripheral neuropathy (Table 5). This evidence concerns the gene CYP3A4 and peripheral neuropathy.